Researchers have discovered a key mechanism underlying bacterial skin colonization in atopic dermatitis, which affects millions around the globe. By identifying a major mechanism through which Staphylococcus aureus binds to the skin of patients with AD the team has opened the possibility of targeting this pathway as a therapeutic option in AD.